Notably, PEGylated CeO2 nanoparticles exhibited a selective clearance of mutp53 and demonstrated cytotoxicity toward p53-mutated cancer cells, highlighting a promising approach to address the challenges associated with mutp53 degradation. The gene discussed is TP53; the disease is cancer.